Fresenius SE & Co. KGaA

Earnings Release • Nov 3, 2005

News Details

Ad-hoc | 3 November 2005 07:31

Fresenius AG:Excellent 1st-3rd quarter of 2005 (final figures)

Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. —————————————————————————— Excellent financial results in the 1st-3rd quarter of 2005 (final figures); full-year earnings outlook confirmed Fresenius Group achieved excellent financial results in the first nine months of 2005. Sales rose 7 % in constant currency and 6 % at actual exchange rates to EUR 5,712 million (Q1-3 2004: EUR 5,399 million). EBIT increased 13 % in constant currency and 12 % at actual exchange rates to EUR 703 million (Q1-3 2004: EUR 628 million). Net income rose 30 % in constant currency and 29 % at actual exchange rates to EUR 161 million (Q1-3 2004: EUR 125 million). Excellent operating results of the two largest business segments Fresenius Medical Care and Fresenius Kabi, lower interest expenses and a lower tax rate contributed to this increase. Earnings per ordinary share were EUR 3.92 (Q1-3 2004: EUR 3.04). Earnings per preference share were EUR 3.94 (Q1-3 2004: EUR 3.06). Fresenius confirms its increased earnings guidance as announced in the preliminary nine-month results release on October 14, 2005 as well as its sales expectation for the full-year 2005 (before the announced acquisitions). The Management Board Bad Homburg v.d.H., November 3, 2005 Fresenius AG Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Deutschland ISIN: DE0005785638 (MDAX); DE0005785604 WKN: 578563; 578560 Listed: Amtlicher Markt in Düsseldorf, Frankfurt (Prime Standard) und München; Freiverkehr in Berlin-Bremen, Hamburg und Stuttgart End of ad hoc announcement (c)DGAP 03.11.2005